Clinical trial
Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
NCT01390870 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- September 30, 2010
- Enrollment
- 400 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.